Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jong-In Kim

Showing results (151-160 of 153) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 153 results.
Biochemical and Biophysical Research Communications|September 21, 2021
The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2Dong-Kyun Ryu, Bobin Kang, Hanmi Noh, et al.
Nature Aging|November 1, 2025
Adapting health, economic and social policies to address population aging in ChinaEvandro F Fang, Yuan Fang, Guobing Chen, et al.
Nature Communications|January 13, 2021
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike proteinCheolmin Kim, Dong-Kyun Ryu, Jihun Lee, et al.
Pageof 16

Showing results (151-160 of 153) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 153 results.
Biochemical and Biophysical Research Communications|September 21, 2021
The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2Dong-Kyun Ryu, Bobin Kang, Hanmi Noh, et al.
Nature Aging|November 1, 2025
Adapting health, economic and social policies to address population aging in ChinaEvandro F Fang, Yuan Fang, Guobing Chen, et al.
Nature Communications|January 13, 2021
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike proteinCheolmin Kim, Dong-Kyun Ryu, Jihun Lee, et al.
Pageof 16